Perigon Wealth Management LLC Decreases Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Perigon Wealth Management LLC lowered its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 17.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 38,036 shares of the company’s stock after selling 8,305 shares during the period. Perigon Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $922,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in ARK Genomic Revolution ETF by 31.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock valued at $75,655,000 after purchasing an additional 698,701 shares during the period. Atom Investors LP raised its holdings in shares of ARK Genomic Revolution ETF by 15.2% during the third quarter. Atom Investors LP now owns 49,131 shares of the company’s stock valued at $1,258,000 after acquiring an additional 6,496 shares in the last quarter. Barclays PLC lifted its stake in ARK Genomic Revolution ETF by 252.7% in the third quarter. Barclays PLC now owns 285,108 shares of the company’s stock worth $7,299,000 after acquiring an additional 204,283 shares during the period. Elmwood Wealth Management Inc. boosted its holdings in ARK Genomic Revolution ETF by 39.7% in the third quarter. Elmwood Wealth Management Inc. now owns 57,766 shares of the company’s stock valued at $1,479,000 after acquiring an additional 16,412 shares in the last quarter. Finally, National Bank of Canada FI increased its position in ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after purchasing an additional 920 shares during the period.

ARK Genomic Revolution ETF Price Performance

BATS:ARKG opened at $27.25 on Friday. The stock has a 50 day moving average of $25.17 and a 200-day moving average of $25.20.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.